Topics
Astrocytoma | Diagnosis | Magnetic resonance imaging
Home > Publications > Topics > Astrocytoma > Diagnosis > Magnetic resonance imaging
Weller
J, de Dios E, Katzendobler S, Corell A, Dénes A,
Schmutzer-Sondergeld M, Javanmardi N, Thon N, Tonn JC, Jakola AS.
The
T1/T2 Ratio is Associated With Resectability in Patients With
Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous
System World Health Organization Grades 2 and 3.
Neurosurgery.
2024 Jun 26. doi:
10.1227/neu.0000000000003069. PMID:
38920377. Observational study˰ ˍ
Onishi S, Kojima M, Yamasaki F, Amatya VJ, Yonezawa U, Taguchi A,
Ozono I, Go Y, Takeshima Y, Hiyama E, Horie N.
T2-FLAIR
mismatch sign, an imaging biomarker for CDKN2A-intact in
non-enhancing astrocytoma, IDH-mutant.
Neurosurg
Rev. 2024 Aug 9;47(1):412. doi:
10.1007/s10143-024-02632-5. PMID:
39117984. Observational study. ˍ
Lee MD, Jain R, Galbraith K, Chen A, Lieberman E, Patel SH,
Placantonakis DG, Zagzag D, Barbaro M, Guillermo Prieto Eibl MDP,
Golfinos JG, Orringer DA, Snuderl M.
T2-FLAIR
Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B
Status in IDH-Mutant Astrocytomas.
Clin
Cancer Res. 2024 Aug 15;30(16):3512-3519. doi:
10.1158/1078-0432.CCR-24-0311. PMID:
38829583. Observational study˰
ˍ